Kyowa Kirin is a biopharmaceutical company that develops and commercializes regenerative medicines and antibody drugs to treat generic diseases. Kyowa Kirin was founded in 2008. Kyowa Kirin's headquarters is located in Chiyoda-ku, Tōkyō Prefecture, JP...
Kyowa Kirin's President & CEO, Masashi Miyamoto, currently has an approval
rating of 90%. Kyowa Kirin's primary competitors are Ono Pharmaceutical, Kirin, Taiho Pharmaceuticaland 7 more.